| Serial Number | 98391050 |
| Word Mark | KANAPH THERAPEUTICS INC. |
| Filing Date | Monday, February 5, 2024 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 14, 2025 |
| Registration Number | 7650919 |
| Registration Date | Tuesday, January 14, 2025 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 26, 2024 |
| Description of Mark | The mark consists of a design comprising four diagonal lines in which the top line is yellow and the remainder are pink, all positioned to the left of the pink stylized word "KANAPH" above the gray stylized wording "THERAPEUTICS INC.". |
| Indication of Colors claimed | The color(s) yellow, pink and gray is/are claimed as a feature of the mark. |
| Goods and Services | Consultation and providing information in the fields of medicine and health |
| NOT AVAILABLE | "THERAPEUTICS INC." |
| Translation of Words in Mark | The wording "KANAPH" has no meaning in a foreign language. |
| Goods and Services | Medicine research, namely, medical research; medical research in the field of pharmaceuticals, surgery and medical specimen analysis; performing biopsies, specifically, medical testing services in the fields of cancer research; blood testing for medical research in the nature of blood analysis services; consultation and providing information in the field of pharmacology; medical and pharmacological research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; consultancy and research in the field of bacteriology; research on the subject of pharmaceuticals; development of treatment preparations for removal of tumors; technical research in the field of removal of tumors; antibodies research; technological research in the field of determining blood type genetic markers; biotechnology research; scientific research in the field of genetics; biological research; laboratory services relating to the production of monoclonal antibodies; scientific research |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 12, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kanaph Therapeutics Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Yongsan-gu, Seoul 04348 KR |
| Party Name | Kanaph Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Yongsan-gu, Seoul 04348 KR |
| Party Name | Kanaph Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Yongsan-gu, Seoul 04348 KR |
| Event Date | Event Description |
| Thursday, February 8, 2024 | NEW APPLICATION ENTERED |
| Tuesday, March 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 13, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, August 28, 2024 | ASSIGNED TO EXAMINER |
| Thursday, August 29, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, August 29, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 29, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, October 28, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 28, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 28, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 4, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Monday, November 4, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Monday, November 4, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, November 4, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, November 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 26, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 26, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 14, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 14, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |